FLNA:BMV
Filana Therapeutics Inc
15,92 MX$
0,00%
(0,00) 1 Д
5. окт, 12:05:31 GMT-6 · MXN
search
Сви симболи
| Симбол | Цена | Промена | % промене |
|---|
insights_autoГенеришу се најзначајнији увиди за FLNA...
Трж. капитализација
35,89 мил.
Прос. количина
0,00
Количина
0,00
Највиша у 52 недеље
56,00 MX$
Најнижа у 52 недеље
15,92 MX$
Бр. запослених
19
Трж. капитализација
35,89 мил.
Прос. количина
0,00
Количина
0,00
Највиша у 52 недеље
56,00 MX$
Најнижа у 52 недеље
15,92 MX$
Бр. запослених
19
Вести
Из веб-извора и од партнера за вести
Blic
·
пре 23 сата
Američke berze počele nedelju neujednačeno! Nafta sve skuplja: Investitori čekaju važne izveštaje
Seeking Alpha
·
пре 1 сата
Biomea Fusion, Inc. (BMEA) Discusses BMF-650 Phase I Topline Results and Potential for Separating GI Side Effects from Weight Loss - Slideshow (NASDAQ:BMEA) 2026-10-14
Stocktwits
·
пре 21 минута
UNH Stock Outpaces S&P 500 In 2026, Eyes Best Year Since Pandemic — CFO Says Wall Street May Be Missing 2027 Upside
Benzinga
·
пре 17 минута
Stock Market: Will S&P 500 Open Up or Down Today?
Профил
Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. Currently led by President and CEO Richard Barry, Filana is working on developing simufilam to treat tuberous sclerosis complex–related epilepsy. The company previously was developing simufilam as an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials.
In June 2024, the United States Department of Justice charged an advisor to Cassava Hoau-Yan Wang, with fraud over research results related to the experimental drug. Less than a month later, the president, chief executive officer and chairman of the board, Remi Barbier, resigned along with Lindsay Burns, his wife, who was the company's senior vice president and Wang's co-author. The U.S. Securities and Exchange Commission filed fraud charges in September 2024 against Barbier, Burns and Wang. The parties did not admit wrongdoing, but agreed to pay fines of the company $40 million, Barbier $175,000, Burns $85,000, and Wang $50,000. Wikipedia
Filana Therapeutics Inc – основни подаци
Главни извршни директор-
Запослени19
Основано1998
СедиштеОстин, Тексас, Сједињене Државе
Сектор-
Веб-сајтpaintrials.com